J Occup Environ Med
Dr. Susan H. Tannenbaum, MD
- Medicare services, 2024
- 310
- Medicare patients, 2024
- 114
- Part D claims, 2024
- 163
- Publications
- 20
- Clinical trials
- 6
- Practice address
- 263 Farmington Ave, Farmington, CT 06030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD
Childrens Hospital outpatient department · Farmington, Connecticut
Find Dr. Tannenbaum's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Susan H. Tannenbaum is a hematologist and oncologist in Farmington, Connecticut
Dr. Tannenbaum practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.
Dr. Tannenbaum's NPI, 1447257704, was assigned on July 1, 2005. Dr. Tannenbaum graduated from State University of New York Downstate Medical Center in 1978. Dr. Tannenbaum holds Connecticut license 041311.
- NPI
- 1447257704NPI Registry (opens in a new tab)
- NPI enumeration date
- July 1, 2005
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Susan H. Tannenbaum practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut
Dr. Tannenbaum's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.
- Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD263 Farmington Ave, Farmington, CT 06030
Source: Dmand AI Affiliation Data
Dr. Susan H. Tannenbaum is affiliated with 2 sites of care and 1 medical group
Dr. Tannenbaum's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Tannenbaum is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Susan H. Tannenbaum's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tannenbaum practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Susan H. Tannenbaum is one of 175 hematologists and oncologists in Connecticut
Hematology and oncology is Dr. Tannenbaum's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tannenbaum is licensed in Connecticut.
Specialties and state licenses
- Hematology and oncology, ConnecticutPrimary
Hematologists and oncologists near Dr. Tannenbaum
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Susan H. Tannenbaum billed Medicare for 310 services in 2024
CMS data shows 310 Medicare services from Dr. Tannenbaum across 3 procedure codes in 2024, for 114 Medicare patients. Medicare paid $17,988 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Tannenbaum's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3922024: 21445%
- Other services
- 2023: 182024: 96433%
Dr. Tannenbaum compared with the Connecticut median for hematologists and oncologists, 2024
- Dr. Tannenbaum
- Connecticut median
- Medicare services
- 310vs 54143% below
- Medicare patients
- 114vs 20845% below
- Part D claims
- 97vs 45178% below
Medians across 168 hematologists and oncologists in Connecticut with Dmand AI profiles that report each measure.
Dr. Tannenbaum's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Tannenbaum?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tannenbaum and other hematologists and oncologists in Connecticut.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Susan H. Tannenbaum treated 114 Medicare patients in 2024, average age 73
CMS counts 114 Medicare patients who saw Dr. Tannenbaum in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have cancer, and 69% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Tannenbaum's median patient age at 74, with 89% women.
Dr. Tannenbaum's Medicare patients by age, 2024
Dr. Tannenbaum's Medicare patients by sex, 2024
- Women9684%
- Men1816%
Chronic conditions among Dr. Tannenbaum's Medicare patients, 2024
- Cancer75%
- High blood pressure69%
- High cholesterol66%
- Arthritis49%
- Osteoporosis47%
- Mood disorders39%
- Anxiety35%
- Depression34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Tannenbaum's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women89%
- Men11%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Susan H. Tannenbaum wrote 163 Medicare Part D claims in 2024
In 2024, Dr. Tannenbaum wrote 163 Medicare Part D claims for 50 patients. 77% of them were for generic drugs. CMS names the drug for 97 of them, across 4 drugs with 11 or more claims each, at $241,166 in total drug cost. In 2023, CMS named 238 claims across 8 drugs.
Dr. Tannenbaum's Part D claims by kind of drug, 2024
- Generic125 claims77%
- Brand-name38 claims23%
Dr. Tannenbaum's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2382024: 9759%
Drugs named by CMS: 4 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Susan H. Tannenbaum has 20 publications on record
Dmand AI links 20 papers to Dr. Tannenbaum, published from 2011 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Chemotherapy, Adjuvant and Neoadjuvant Therapy. Dr. Tannenbaum has published most often in Breast Cancer Res. Dr. Tannenbaum's most frequent co-authors are Patricia A. Defusco, MD, Erick T. Avelar, MD and Ravi S. Marfatia, MD.
Dr. Tannenbaum's papers by year, 2011 to 2023
Topics Dr. Tannenbaum writes about most
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Neoadjuvant Therapy
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Ductal, Breast
- Magnetic Resonance Imaging
- Receptor, ErbB-2
- Survivors
Dr. Tannenbaum's most frequent co-authors
- Patricia A. Defusco, MD3 shared papers
- Erick T. Avelar, MD2 shared papers
- Ravi S. Marfatia, MD2 shared papers
Recent publications by Dr. Tannenbaum
J Cancer Surviv
See who Dr. Tannenbaum researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tannenbaum works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Susan H. Tannenbaum has worked on 6 clinical trials
Dmand AI links Dr. Tannenbaum to 6 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Breast Neoplasms, Male.
Clinical trials with Dr. Tannenbaum by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Tannenbaum's trials
- Breast Neoplasms
- Breast Diseases
- Breast Neoplasms, Male
- Carcinoma, Adenoid Cystic
- Carcinoma, Intraductal, Noninfiltrating
Investigators on the most trials with Dr. Tannenbaum
- Bamidele A. Adesunloye, MD2 shared trials
- Mitchell B. Alden, DO2 shared trials
- Blair Ardman, MD2 shared trials
Recent clinical trials with Dr. Tannenbaum
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001) (opens in a new tab)
A Phase I Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma (opens in a new tab)
T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer (opens in a new tab)
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Susan H. Tannenbaum received $10,346 in industry payments from 2016 to 2019
CMS Open Payments shows 20 general payments to Dr. Tannenbaum from 5 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $6,927.
General payments to Dr. Tannenbaum by program year, 2016 to 2019
General payments to Dr. Tannenbaum by kind, 2016 to 2019
- Consulting fees$8,10078%
- Travel and lodging$1,74217%
- Food and beverage$4544%
- Education$500%
Companies that paid Dr. Tannenbaum the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Susan H. Tannenbaum graduated from State University of New York Downstate Medical Center
Dr. Tannenbaum graduated from State University of New York Downstate Medical Center in 1978.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Susan H. Tannenbaum's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Susan H. Tannenbaum
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Susan H. Tannenbaum's NPI number?
Dr. Susan H. Tannenbaum's NPI number is 1447257704. It was assigned on July 1, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Susan H. Tannenbaum?
Dr. Susan H. Tannenbaum is a hematologist and oncologist in Farmington, Connecticut. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Susan H. Tannenbaum practice?
Dr. Tannenbaum practices at 263 Farmington Ave, Farmington, CT 06030. Dr. Tannenbaum's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.
What is Dr. Susan H. Tannenbaum's medical license number?
Dr. Tannenbaum holds Connecticut license 041311.
Which hospitals is Dr. Susan H. Tannenbaum affiliated with?
Dr. Tannenbaum is affiliated with UConn John Dempsey Hospital.
What medical group is Dr. Susan H. Tannenbaum part of?
Dr. Tannenbaum is linked to UConn Medical Group.
Does Dr. Susan H. Tannenbaum accept Medicare?
Yes. CMS data shows Dr. Tannenbaum billed Medicare for 310 services in 2024.
How many Medicare patients does Dr. Susan H. Tannenbaum see?
CMS counts 114 Medicare patients who saw Dr. Tannenbaum in 2024, with an average age of 73.
What services does Dr. Susan H. Tannenbaum bill to Medicare?
In 2024, Dr. Tannenbaum's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99215).
Where did Dr. Susan H. Tannenbaum go to medical school?
Dr. Tannenbaum graduated from State University of New York Downstate Medical Center in 1978.
Show 5 more questionsShow fewer questions
What drugs does Dr. Susan H. Tannenbaum prescribe most?
In 2024 Medicare Part D data, Dr. Tannenbaum's most prescribed drugs by claims were Anastrozole, Ibrance and Tamoxifen Citrate.
Has Dr. Susan H. Tannenbaum received payments from drug or device companies?
CMS Open Payments shows $10,346 in general payments to Dr. Tannenbaum from 5 companies from 2016 to 2019. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Susan H. Tannenbaum been practicing?
Dr. Tannenbaum graduated from medical school in 1978, 48 years ago.
Does Dr. Susan H. Tannenbaum do research?
Dmand AI links 20 publications to Dr. Tannenbaum, published from 2011 to 2023. Dr. Tannenbaum has worked on 6 clinical trials.
Who does Dr. Susan H. Tannenbaum publish with?
Dr. Tannenbaum's most frequent co-authors are Patricia A. Defusco, MD (3 shared papers), Erick T. Avelar, MD (2 shared papers) and Ravi S. Marfatia, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card